Elizabeta A. Rojas
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Study of post-translational modifications of p53 in multiple myeloma.
Journal: Blood cancer journal
Published: December 10, 2025
Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation.
Journal: Molecular oncology
Published: February 26, 2025
PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma.
Journal: Leukemia
Published: May 10, 2024
Expression profile of Bcl-2 family proteins in newly diagnosed multiple myeloma patients.
Journal: HemaSphere
Published: April 24, 2024
Regression of Glaukomflecken in Urrets-Zavalía syndrome after myopic ICL implantation.
Journal: Journal francais d'ophtalmologie
Published: November 25, 2023
Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling.
Journal: Haematologica
Published: May 05, 2023
Transcriptional signature of TP53 biallelic inactivation identifies a group of multiple myeloma patients without this genetic condition but with dismal outcome.
Journal: British journal of haematology
Published: May 23, 2022
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.
Journal: American journal of hematology
Published: November 04, 2021
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation.
Journal: Experimental hematology & oncology
Published: November 01, 2021
Effect of Graphene Family Materials on Multiple Myeloma and Non-Hodgkin's Lymphoma Cell Lines.
Journal: Materials (Basel, Switzerland)
Published: June 16, 2020
Last Updated: 09/26/2026